Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Neuroendocrine Tumor G2 × Octreotide × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Gastrointestinal 1 Endocrine 1

Conditions

Neuroendocrine Tumors 12 Gastro-enteropancreatic neuroendocrine tumor 3 Carcinoid Tumor 3 Neoplasms 2 Carcinoma, Islet Cell 2 Adenoma, Islet Cell 2 Vipoma 1 Somatostatinoma 1 Serotonin Syndrome 1 Pancreatic Neuroendocrine Tumor G2 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Insulinoma 1 Glucagonoma 1 Gastrinoma 1 Carcinoma, Hepatocellular 1 Carcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06080204 2023-10-18

Real-world Study on Adjuvant Octreotide Therapy in pNETs

Changhai Hospital

Phase NA Completed

EndocrineGastrointestinalNET

Pancreatic Neuroendocrine Tumor G2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡